Optimal strategies of oncolytic virus-bortezomib therapy via the apoptotic, necroptotic, and oncolysis signaling network
Bortezomib and oncolytic virotherapy are two emerging targeted cancer therapies. Bortezomib, a proteasome inhibitor, disrupts protein degradation in cells, leading to the accumulation of unfolded proteins that induce apoptosis. On the other hand, virotherapy uses genetically modified oncolytic virus...
Main Authors: | Donggu Lee, Aurelio A. de los Reyes V, Yangjin Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2024-02-01
|
Series: | Mathematical Biosciences and Engineering |
Subjects: | |
Online Access: | https://www.aimspress.com/article/doi/10.3934/mbe.2024173?viewType=HTML |
Similar Items
-
Synergistic Effects of Bortezomib-OV Therapy and Anti-Invasive Strategies in Glioblastoma: A Mathematical Model
by: Yangjin Kim, et al.
Published: (2019-02-01) -
Myxoma Virus Combination Therapy Enhances Lenalidomide and Bortezomib Treatments for Multiple Myeloma
by: Alpay Yeşilaltay, et al.
Published: (2024-01-01) -
Combination of Oncolytic Measles Virus and Ursolic Acid Synergistically Induces Oncolysis of Hepatocellular Carcinoma Cells
by: Ching-Hsuan Liu, et al.
Published: (2023-05-01) -
Oncolytic viruses as anticancer vaccines
by: Norman eWoller, et al.
Published: (2014-07-01) -
Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
by: Junior A. Enow, et al.
Published: (2023-11-01)